These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2434090)

  • 1. Biotransformation of 1-nitropyrene and 2-nitrofluorene to novel metabolites, the corresponding formylamino compounds, in animal bodies.
    Tatsumi K; Amano H
    Biochem Biophys Res Commun; 1987 Jan; 142(2):376-82. PubMed ID: 2434090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on metabolic formation of N-arylformamides and N-arylacetamides from carcinogenic arylamines in mammalian species.
    Tatsumi K; Kitamura S; Amano H; Ueda K
    Cancer Res; 1989 Apr; 49(8):2059-64. PubMed ID: 2702648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of metabolic activation of carcinogens in human, rat, and hamster hepatocytes.
    Synder S; Hsu IC; Trump BF
    Mutat Res; 1987 Feb; 182(1):31-9. PubMed ID: 3100948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte enzymes catalyze 1-nitropyrene and 3-nitrofluoranthene nitroreduction.
    Belisario MA; Pecce R; Garofalo A; Sannolo N; Malorni A
    Toxicology; 1996 Apr; 108(1-2):101-8. PubMed ID: 8644108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo metabolism of the carcinogen 4-nitropyrene.
    Upadhyaya P; Von Tungeln LS; Fu PP; el-Bayoumy K
    Chem Res Toxicol; 1994; 7(5):690-5. PubMed ID: 7841349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ring oxidation in the metabolic activation of 1-nitropyrene.
    Beland FA
    Res Rep Health Eff Inst; 1991 Dec; (46):1-22; discussion 23-33. PubMed ID: 1777157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the in vitro and in vivo hepatic metabolism of the carcinogen 1-nitropyrene.
    Howard PC; Flammang TJ; Beland FA
    Carcinogenesis; 1985 Feb; 6(2):243-9. PubMed ID: 3838267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the major metabolites and DNA adducts formed from 2-nitropyrene in vitro.
    Roy AK; Upadhyaya P; Fu PP; el-Bayoumy K
    Carcinogenesis; 1991 Mar; 12(3):475-9. PubMed ID: 2009592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism in vivo of 1-nitropyrene, an environmental pollutant, in fish.
    Kitamura S; Tatsumi K
    Biol Pharm Bull; 1996 Nov; 19(11):1524-6. PubMed ID: 8951180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and DNA binding of 1-nitropyrene and 1-nitrosopyrene in newborn mice.
    el-Bayoumy K; Shiue GH; Hecht SS
    Chem Res Toxicol; 1988; 1(4):243-7. PubMed ID: 2979739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of K-region derivatives of 1-nitropyrene by rat liver in vitro.
    Roy AK; el-Bayoumy K; Hecht SS
    Carcinogenesis; 1988 Feb; 9(2):255-8. PubMed ID: 3338108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetics of 1-nitropyrene and 3-nitrofluoranthene metabolism using bovine liver xanthine oxidase.
    Bauer SL; Howard PC
    Cancer Lett; 1990 Oct; 54(1-2):37-42. PubMed ID: 2208087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of in vivo binding of aromatic nitro and amino compounds to rat hemoglobin.
    Suzuki J; Meguro S; Morita O; Hirayama S; Suzuki S
    Biochem Pharmacol; 1989 Oct; 38(20):3511-9. PubMed ID: 2818643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative microsomal metabolism of 1-nitropyrene and DNA-binding of oxidized metabolites following nitroreduction.
    Djurić Z; Fifer EK; Howard PC; Beland FA
    Carcinogenesis; 1986 Jul; 7(7):1073-9. PubMed ID: 3755082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further metabolism of 2-formylaminofluorene, a metabolite of 2-aminofluorene, in rats.
    Ueda O; Kitamura S; Tatsumi K
    Biol Pharm Bull; 1996 Feb; 19(2):330-3. PubMed ID: 8850336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of 1-nitropyrene to 1-aminopyrene and N-formyl-1-aminopyrene by the human intestinal microbiota.
    Manning BW; Cerniglia CE; Federle TW
    J Toxicol Environ Health; 1986; 18(3):339-46. PubMed ID: 3519993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of the carcinogen 1-nitropyrene to 1-aminopyrene by rat intestinal bacteria.
    Howard PC; Beland FA; Cerniglia CE
    Carcinogenesis; 1983 Aug; 4(8):985-90. PubMed ID: 6347427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of copollutants on the metabolism and DNA binding of carcinogens.
    Howard PC; Beland FA
    Res Rep Health Eff Inst; 1994 May; (66):1-17; discussion 19-25. PubMed ID: 7521645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 1-nitropyrene by human, rat, and mouse intestinal flora: mutagenicity of isolated metabolites by direct analysis of HPLC fractions with a microsuspension reverse mutation assay.
    King LC; Kohan MJ; George SE; Lewtas J; Claxton LD
    J Toxicol Environ Health; 1990 Nov; 31(3):179-92. PubMed ID: 2231777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and mutagenicity of metabolites of 1-nitropyrene formed by rat liver.
    El-Bayoumy K; Hecht SS
    Cancer Res; 1983 Jul; 43(7):3132-7. PubMed ID: 6687833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.